6957 people have viewed this drug in the last 60 days
Updated 2025-06-02
Last Update | 2023-01-30 |
Register Year | 2017 |
Product Type | Human |
Drug Type | Biological |
Scientific Name | USTEKINUMAB |
Trade Name | STELARA 130MG/26ML Concentrate for solution for infusion |
Strength Unit | mg |
Pharmaceutical Form | Solution for injection in pre-filled syringe |
Administration Route | Intravenous use |
Atc Code1 | L04AC |
Atc Code2 | |
Size | 26 |
Size Unit | ml |
Package Types | Vial |
Package Size | 1 |
Legal Status | Prescription |
Product Control | Uncontrolled |
Distribute Area | Hospital |
Public price | $11057.25 |
Shelf Life | 36 Months |
Marketing Company | Janssen-Cilag International NV |
Marketing Country | Belgium |
Manufacture Name | JANSSEN-CILAG |
Manufacture Country | Switzerland |
Secondry package manufacture | |
Main Agent | Cigalah Group |
Secosnd Agent | |
Third Agent | |
Visits | 6957 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
Name | Price | Visits | Updated |
---|---|---|---|
STELARA 130MG/26ML Concentrate for solut | $11057.25 | 6957 visits | 2023-01-30 |
STELARA 45MG/0.5ML SOLUTION FOR INJECTIO | $11103.25 | 140425 visits | 2023-03-28 |
STELARA 90mg/1ml SOLUTION FOR INJECTION | $11103.25 | 131178 visits | 2023-03-28 |